- Oxygen Free Radical Release in Human Failing Myocardium Is Associated With Increased Activity of Rac1-GTPase and Represents a Target for Statin Treatment
Circulation · 2003
- Simvastatin Rescues Rats From Fatal Pulmonary Hypertension by Inducing Apoptosis of Neointimal Smooth Muscle Cells
Circulation · 2003
- Lipid-Lowering Drugs and the Risk of Depression and Suicidal Behavior
Archives of Internal Medicine · 2003
- Effects of exercise training on conduit and resistance vessel function in treated and untreated hypercholesterolaemic subjects
European Heart Journal · 2003
- Treatment with amlodipine andatorvastatin have additive effect in improvement of arterial compliance in hypertensive hyperlipidemic patients
American Journal of Hypertension · 2003
- Noncholesterol-Lowering Effects of Statins
Vascular and Endovascular Surgery · 2003
- Attenuation of chronic hypoxic pulmonary hypertension by simvastatin
American Journal of Physiology-Heart and Circulatory Physiology · 2003
- Anti-inflammatory Effects of Statins in Patients with Aortic Stenosis
Journal of Cardiovascular Pharmacology and Therapeutics · 2003
- Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin.
2003
- Lack of Adverse Clopidogrel–Atorvastatin Clinical Interaction From Secondary Analysis of a Randomized, Placebo-Controlled Clopidogrel Trial
Circulation · 2003
- Statin therapy restores sympathovagal balance in experimental heart failure
Journal of Applied Physiology · 2003
- Short-Term Statin Therapy Improves Cardiac Function and Symptoms in Patients With Idiopathic Dilated Cardiomyopathy
Circulation · 2003
- Valvular heart disease.
2003
- Physicians' ability to predict the risk of coronary heart disease
BMC Health Services Research · 2003
- Reduction of myocardial infarct size by fluvastatin
American Journal of Physiology-Heart and Circulatory Physiology · 2003
- Lipid Management and the Elderly
Preventive Cardiology · 2003
- Aggressive Lipid Management for Cardiovascular Prevention: Evidence from Clinical Trials
Experimental Biology and Medicine · 2003
- Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients
Journal of the American College of Cardiology · 2003
- Therapeutic approaches to dyslipidemia in diabetes mellitus and metabolic syndrome
Current Opinion in Cardiology · 2003
- A strategy to reduce cardiovascular disease by more than 80%
BMJ · 2003
- Simvastatin–Fluconazole Causing Rhabdomyolysis
Annals of Pharmacotherapy · 2003
- Update of Clinical Trials from the American College of Cardiology 2003. EPHESUS, SPORTIF-III, ASCOT, COMPANION, UK-PACE and T-Wave Alternans
European Journal of Heart Failure · 2003
- Management of stable angina
Postgraduate Medical Journal · 2003
- Platelet Activation, Inflammatory Mediators and Hypercholesterolemia
Current Vascular Pharmacology · 2003
- A RATIONAL BASIS FOR SELECTION AMONG DRUGS OF THE SAME CLASS
Heart · 2003
- Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care
British Journal of Clinical Pharmacology · 2003
- Calcific aortic stenosis: another face of atherosclerosis?
Cleveland Clinic Journal of Medicine · 2003
- New developments in the pharmacological treatment of chronic heart failure
Expert Opinion on Investigational Drugs · 2003
- Treatment of children with familial hypercholesterolemia
Expert Review of Cardiovascular Therapy · 2003
- Influence of Simvastatin on Aspects of Thrombogenesis in CAPD Patients
Peritoneal Dialysis International · 2003
- Statins Are Associated With a Reduced Incidence of Perioperative Mortality in Patients Undergoing Major Noncardiac Vascular Surgery
Circulation · 2003
- Arterial hypertension and ischaemic stroke
Acta Neurologica Scandinavica · 2003
- The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk.
2003
- Rosuvastatin, a New HMG-CoA Reductase Inhibitor, Protects Ischemic Reperfused Myocardium in Normocholesterolemic Rats
Journal of Cardiovascular Pharmacology · 2003
- LIFE and ARBITER
Preventive Cardiology · 2003
- Benefits of statin therapy in patients with special risks: Coronary bypass surgery, stable coronary disease, and acute coronary syndromes
Clinical Cardiology · 2003
- Evolution of statin prescribing 1994–2001: a case of agism but not of sexism?
Heart · 2003
- THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Traditional Cardiac Risk Factors in Individuals with Chronic Kidney Disease
Seminars in Dialysis · 2003
- Statin Use and Leg Functioning in Patients With and Without Lower-Extremity Peripheral Arterial Disease
Circulation · 2003
- Atorvastatin, administered at the onset of reperfusion, and independent oflipid lowering, protects the myocardiumby up-regulating a pro-survival pathway
Journal of the American College of Cardiology · 2003
- Low‐dose atorvastatin therapy does not augment endothelial function in active hypercholesterolaemic males
British Journal of Clinical Pharmacology · 2003
- Effect of High-Dose Statin Treatment on Plasma Concentrations of Endogenous Nitric Oxide Synthase Inhibitors
Journal of Cardiovascular Pharmacology · 2003
- Atorvastatin causes depressor and sympatho-inhibitory effects with upregulation of nitric oxide synthases in stroke-prone spontaneously hypertensive rats
Journal of Hypertension · 2003
- Effect of Nifedipine and Cerivastatin on Coronary Endothelial Function in Patients With Coronary Artery Disease
Circulation · 2003
- Pravastatin for Secondary Prevention of Cardiovascular Events in Persons with Mild Chronic Renal Insufficiency
Annals of Internal Medicine · 2003
- C-Reactive Protein and Ischemia in Users and Nonusers of β-Blockers and Statins
Circulation · 2003
- HMG-CoA Reductase Inhibitors Are Associated with Decreased Serum Neopterin Levels in Stable Coronary Artery Disease
Clinical Chemistry and Laboratory Medicine (CCLM) · 2003
- Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation
Circulation · 2003
- Simvastatin Initiated Early After Heart Transplantation
Circulation · 2003
- Fluvastatin Enhances the Inhibitory Effects of a Selective Angiotensin II Type 1 Receptor Blocker, Valsartan, on Vascular Neointimal Formation
Circulation · 2003